Hims & Hers Health, Inc.(HIMS)— Stock Profile, AI Score & Financials

Healthcare · NYSE · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

Hims & Hers Health, Inc. (HIMS) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores HIMS at 53.4/100 on a 32-signal composite quality model, placing it at rank #1,390 of 2,961 stocks — the top half of the AI-ranked universe. HIMS scores in the top quartile across revenue growth (94.7), earnings quality (81.6). Areas of concern include profitability (21.2) and balance sheet strength (22.9), which score below median versus the broader universe. Shareholder dilution risk is elevated at 22.8/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), Hims & Hers Health, Inc. reports quarterly revenue of $753.2M, net income of $-86.3M, free cash flow of $-68.2M. Top institutional holders of HIMS by reported 13-F value include BlackRock, SUSQUEHANNA INTERNATIONAL GROUP, LLP, VANGUARD PORTFOLIO MANAGEMENT, based on the most recent SEC filings. HIMS trades on the NYSE exchange and files with the SEC under CIK 1773751. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate HIMS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Hims & Hers Health, Inc. directly from SEC EDGAR.